Ibu-Lysin Doppelherzpharma Doppelherz Pharma

Ibuprofen lysinate, the active ingredient in Ibu-Lysin Doppelherzpharma, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is used to relieve pain, reduce fever, and lessen inflammation in adults and adolescents when appropriate. GNH USA supplies Ibu-Lysin Doppelherzpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibu-Lysin (ibuprofen lysinate) belongs to the NSAID class and works by reducing prostaglandin synthesis, which helps manage several common conditions.

Pain relief: alleviates mild to moderate pain such as headaches, dental pain, or musculoskeletal discomfort. Fever reduction: lowers elevated body temperature associated with infections or inflammatory states. Inflammation: diminishes swelling and redness in conditions like arthritis or soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort, such as dyspepsia or heartburn. - Nausea or vomiting. - Headache. - Dizziness. - Mild skin rash. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe allergic reactions, including anaphylaxis. - Hepatic dysfunction or elevated liver enzymes. - Cardiovascular events such as myocardial infarction or stroke. - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before using Ibu-Lysin, consider the following safety measures.

Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. Use lowest effective dose: limit duration to the shortest period needed for symptom control. Monitor renal function: caution in patients with existing kidney disease or dehydration. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Pregnancy and lactation: consult a healthcare professional before use. Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ibu-Lysin may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: synergistic ulcerogenic effect. - ACE inhibitors or ARBs: potential reduction in renal function. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive effect. - Methotrexate: decreased clearance leading to toxicity. - SSRIs: modest increase in bleeding tendency. - Antihypertensive agents: may blunt blood pressure control. - Antidiabetic drugs: potential alteration of glucose control.